Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA temporary NIH announcement about transition updates and terminology is no longer shown above the ClinicalTrials.gov page.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide notice about NIH terminology during a transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and blocking access to the study details. This is an access issue rather than an update to core page content such as the study description or eligibility criteria.SummaryDifference19%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.